Literature DB >> 20438820

Passive asymmetric transport of hesperetin across isolated rabbit cornea.

Ramesh Srirangam1, Soumyajit Majumdar.   

Abstract

Hesperetin, an aglycone of the flavanone hesperidin, is a potential candidate for the treatment of diabetic retinopathy and macular edema. The purpose of this investigation was to determine solubility, stability and in vitro permeability characteristics of hesperetin across excised rabbit corneas. Aqueous and pH dependent solubility was determined using standard shake flask method. Solution stability was evaluated as a function of pH (1.2-9) and temperature (25 and 40 degrees C). Permeability of hesperetin was determined across the isolated rabbit cornea utilizing a side-bi-side diffusion apparatus, in the apical to basolateral (A-B) and basolateral to apical (B-A) directions. Hesperetin displayed asymmetrical transcorneal transport with a 2.3-fold higher apparent permeability in the B-A direction compared to the A-B direction. The transport process was observed to be pH dependent. Surprisingly, however, the involvement of efflux transporters or proton-coupled carrier-systems was not evident in this asymmetric transcorneal diffusion process. The passive and pH dependent corneal transport of hesperetin could probably be attributable to corneal ultrastructure, physicochemical characteristics of hesperetin and the role of transport buffer components. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20438820      PMCID: PMC2892274          DOI: 10.1016/j.ijpharm.2010.04.036

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  26 in total

Review 1.  Chemistry and pharmacology of the Citrus bioflavonoid hesperidin.

Authors:  A Garg; S Garg; L J Zaneveld; A K Singla
Journal:  Phytother Res       Date:  2001-12       Impact factor: 5.878

2.  The effect of co-administered flavonoids on the metabolism of hesperetin and the disposition of its metabolites in Caco-2 cell monolayers.

Authors:  Walter Brand; Beatriz Padilla; Peter J van Bladeren; Gary Williamson; Ivonne M C M Rietjens
Journal:  Mol Nutr Food Res       Date:  2010-06       Impact factor: 5.914

3.  Insulin aggregation and asymmetric transport across human bronchial epithelial cell monolayers (Calu-3).

Authors:  Isabelle Pezron; Ranjana Mitra; Dahnanjay Pal; Ashim K Mitra
Journal:  J Pharm Sci       Date:  2002-04       Impact factor: 3.534

4.  Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen-induced aberrant crypt foci in colon cancer rats: a dose-dependent study.

Authors:  Selvaraj Aranganathan; Jayabal Panneer Selvam; Namasivayam Nalini
Journal:  J Pharm Pharmacol       Date:  2008-10       Impact factor: 3.765

5.  Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  Pharm Res       Date:  2008-09-23       Impact factor: 4.200

6.  Effluxing ABC transporters in human corneal epithelium.

Authors:  Kati-Sisko Vellonen; Eliisa Mannermaa; Helen Turner; Marika Häkli; J Mario Wolosin; Timo Tervo; Paavo Honkakoski; Arto Urtti
Journal:  J Pharm Sci       Date:  2010-02       Impact factor: 3.534

7.  Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells.

Authors:  Yu-Yuan Chiu; Kazutaka Higaki; Brien L Neudeck; Jeffrey L Barnett; Lynda S Welage; Gordon L Amidon
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

8.  Evaluation of active and passive transport processes in corneas extracted from preserved rabbit eyes.

Authors:  Soumyajit Majumdar; Tushar Hingorani; Ramesh Srirangam
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

9.  Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesis.

Authors:  Selvaraj Aranganathan; Jayabal Panneer Selvam; Namasivayam Nalini
Journal:  Invest New Drugs       Date:  2008-07-22       Impact factor: 3.850

10.  Neuroprotective effects of chronic hesperetin administration in mice.

Authors:  Eun Jeong Choi; Woong Shick Ahn
Journal:  Arch Pharm Res       Date:  2008-11-21       Impact factor: 4.946

View more
  9 in total

1.  Evaluation of topical hesperetin matrix film for back-of-the-eye delivery.

Authors:  Goutham R Adelli; Tushar Hingorani; Nagendra Punyamurthula; Sai Prachetan Balguri; Soumyajit Majumdar
Journal:  Eur J Pharm Biopharm       Date:  2015-02-26       Impact factor: 5.571

2.  Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System.

Authors:  Nadia Bou-Chacra; Katherine Jasmine Curo Melo; Ivan Andrés Cordova Morales; Erika S Stippler; Filippos Kesisoglou; Mehran Yazdanian; Raimar Löbenberg
Journal:  AAPS J       Date:  2017-05-17       Impact factor: 4.009

3.  Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin.

Authors:  María Sebastián-Morelló; María Aracely Calatayud-Pascual; Vicent Rodilla; Cristina Balaguer-Fernández; Alicia López-Castellano
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

4.  Intravitreal kinetics of hesperidin, hesperetin, and hesperidin G: effect of dose and physicochemical properties.

Authors:  Ramesh Srirangam; Ketan Hippalgaonkar; Soumyajit Majumdar
Journal:  J Pharm Sci       Date:  2012-01-06       Impact factor: 3.534

5.  Evaluation of the intravenous and topical routes for ocular delivery of hesperidin and hesperetin.

Authors:  Ramesh Srirangam; Ketan Hippalgaonkar; Bharathi Avula; Ikhlas A Khan; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2012-07-13       Impact factor: 2.671

6.  A Comparative Study of Hesperetin, Hesperidin and Hesperidin Glucoside: Antioxidant, Anti-Inflammatory, and Antibacterial Activities In Vitro.

Authors:  Sung-Sook Choi; Sun-Hyung Lee; Kyung-Ae Lee
Journal:  Antioxidants (Basel)       Date:  2022-08-20

7.  Stability, clinical efficacy, and antioxidant properties of Honeybush extracts in semi-solid formulations.

Authors:  Gezina S F W Gerber; Lizelle T Fox; Minja Gerber; Jan L du Preez; Sterna van Zyl; Banie Boneschans; Jeanetta du Plessis
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

8.  Therapeutic activity of sour orange albedo extract and abundant flavanones loaded silica nanoparticles against acrylamide-induced hepatotoxicity.

Authors:  M Z Rizk; D M Abo-El-Matty; H F Aly; H I Abd-Alla; S M Saleh; E A Younis; A M Elnahrawy; A A Haroun
Journal:  Toxicol Rep       Date:  2018-09-09

9.  Ex-Vivo Trans-Corneal and Trans-Scleral Diffusion Studies with Ocular Formulations of Glutathione as an Antioxidant Treatment for Ocular Diseases.

Authors:  María Sebastián-Morelló; Adrián M Alambiaga-Caravaca; María Aracely Calatayud-Pascual; Vicent Rodilla; Cristina Balaguer-Fernández; María Miranda; Alicia López-Castellano
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.